Spyre Therapeutics Inc (SYRE) with a beta value of 2.87 appears to be a promising investment opportunity.
Spyre Therapeutics Inc (NASDAQ: SYRE) on Friday, soared 3.16% from the previous trading day, before settling in for the closing price of $23.13. Within the